FAVORITO TAMARA A
SEC insider (Form 3/4/5 filer). CIK 0001288232. Director at ARTELO BIOSCIENCES, INC. (ARTL) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 17, 2026. Located in SOLANA BEACH, CA.
Companies FAVORITO TAMARA A has filed insider reports for
- ARTELO BIOSCIENCES, INC. (ARTL): Director
- ZEVRA THERAPEUTICS, INC. (ZVRA): Director
FAVORITO TAMARA A
CIK: 0001288232
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 17, 2026ARTL
ARTELO BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
136 shares- - Jun 4, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - Jan 30, 2026ARTL
ARTELO BIOSCIENCES, INC.
AwardDirectStock Options (right to buy)
292 shares- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
ConversionDirectConvertible Promissory Note
0 shares at avg. $25000.00- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
ConversionDirectConvertible Promissory Note
0 shares at avg. $19793.00- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
ConversionDirectWarrant (right to buy)
12.6K shares- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
ConversionDirectWarrant (right to buy)
6.8K shares- - Sep 12, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
PurchaseDirect3.2K shares at avg. $7.79$25K - May 29, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - May 1, 2025ARTL
ARTELO BIOSCIENCES, INC.
PurchaseIndirectConvertible Promissory Note
0 shares at avg. $25000.00-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 17, 2026 |  ARTL ARTELO BIOSCIENCES, INC. | Award Stock Option (right to buy) | 136 | - | - | Direct |
| Jun 4, 2026 |  ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jan 30, 2026 | ARTL ARTELO BIOSCIENCES, INC. | Award Stock Options (right to buy) | 292 | - | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion Convertible Promissory Note | 0 | $25000.00 | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion Convertible Promissory Note | 0 | $19793.00 | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion Warrant (right to buy) | 12,566 | - | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion Warrant (right to buy) | 6,846 | - | - | Direct |
| Sep 12, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Purchase | 3,175 | $7.79 | $24,718 | Direct |
| May 29, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| May 1, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Purchase Convertible Promissory Note | 0 | $25000.00 | - | Indirect |
1-10 of 11 transactions